If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
210.50    -3.00 (-1.41%)
Bid:
211.50
Ask:
213.00
Spread: 1.50 (0.709%)
Market Cap: £560.20m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

18 Sep 2025 14:00

RNS Number : 9239Z
Costain Group PLC
18 September 2025
 

 

 

Costain Group PLC (the 'Company')

18 September 2025

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the interim dividend for the year ending 31 December 2025 is 127.28 pence per ordinary share of 1 pence each.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 11 September 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the interim dividend for the year ending 31 December 2025 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 26 September 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The interim dividend for the year ending 31 December 2025, including the scrip dividend, will be paid on 17 October 2025 (the dividend payment date), to the ordinary shareholders of the Company on the register at close of business on 12 September 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

 

Investors and analysts

matt.jones@costain.com 

Matthew Jones, Costain

+44 (0) 7860 922 341

Financial media - Headland

costain@headlandconsultancy.com 

Andy Rivett-Carnac

+44 (0) 7968 997 365

Charlie Twigg

+44 (0) 7946 494 568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVZZGMLMRGGKZM
Date   Source Headline
26th Feb 20198:32 amRNSHolding(s) in Company
25th Feb 20192:18 pmRNSHolding(s) in Company
6th Feb 201911:56 amRNSHolding(s) in Company
15th Jan 201911:49 amRNSHolding(s) in Company
9th Jan 201911:54 amRNSHolding(s) in Company
3rd Jan 20197:00 amRNSYear End Trading Update
2nd Jan 20198:00 amRNSBlock listing Interim Review
2nd Jan 20198:00 amRNSTotal Voting Rights
19th Dec 20183:33 pmRNSHolding(s) in Company
30th Nov 20182:31 pmRNSTotal Voting Rights
30th Nov 20187:00 amRNSNotice of Analyst Event
7th Nov 20187:00 amRNSSix-year framework contract award
29th Oct 20187:00 amRNSBlock Listing Application
17th Oct 20187:00 amRNSA2/M2 connected corridor trial
16th Oct 20187:00 amRNS2018 Interim Dividend - Scrip Alternative
26th Sep 20183:57 pmRNSHolding(s) in Company
24th Sep 20181:00 pmRNSDirector/PDMR Shareholding
20th Sep 20188:41 amRNSScrip Dividend Reference Price
23rd Aug 20187:00 amRNSNetwork Rail 'Meerkat' Technology Contract
22nd Aug 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSConnected Vehicle Technology Contract
10th Jul 20189:03 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
2nd Jul 20188:00 amRNSBlock listing Interim Review
29th Jun 20183:37 pmRNSHolding(s) in Company
22nd Jun 20188:38 amRNSHolding(s) in Company
14th Jun 20187:00 amRNSCostain expands to new technology centre
5th Jun 20183:49 pmRNSDirector/PDMR Shareholding
4th Jun 20187:00 amRNSCostain awarded M6 smart motorway contract
31st May 20189:00 amRNSTotal Voting Rights
15th May 20187:00 amRNSDividend - Scrip Alternative
8th May 20184:29 pmRNSResult of AGM
8th May 20187:00 amRNSCostain awarded technology contract
8th May 20187:00 amRNSAGM Statement
30th Apr 20188:00 amRNSTotal Voting Rights
19th Apr 20188:55 amRNSScrip Dividend Reference Price
11th Apr 20181:16 pmRNSDirector/PDMR Shareholding
4th Apr 20182:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20189:41 amRNSDirector Declaration
29th Mar 20189:01 amRNSTotal Voting Rights
26th Mar 20188:50 amRNSHolding(s) in Company
16th Mar 20189:18 amRNSNotice of AGM
13th Mar 201812:53 pmRNSExercise of Nil Cost Options
13th Mar 201811:58 amRNSHolding(s) in Company
12th Mar 20181:49 pmRNSHolding(s) in Company
6th Mar 20189:00 amRNSLong Term Incentive Plan - Listing Application
1st Mar 20187:00 amRNSFinal Results
28th Feb 20189:00 amRNSTotal Voting Rights
28th Feb 20188:38 amRNSHolding(s) in Company
26th Feb 201810:07 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.